BCMU
BIOA

BlueCrest Capital Management (UK)’s BioAmber Inc. BIOA Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,900
Closed -$136K – 771
2014
Q1 		$136K Buy
+11,900
New +$141K 0.01% 479

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NIMI
Natixis Investment Managers International Paris, France $1.29B AUM 24.83% 1-Year Est. Return

BlueCrest Capital Management (UK)'s BIOA Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of BioAmber Inc. (BIOA) in Q2 2014, closing a stake of 11,900 shares — an estimated $136K sold.

BlueCrest Capital Management (UK) first reported a position in BIOA in Q1 2014 and held it in 1 quarter. The position peaked at $136K in Q1 2014. 24 funds tracked by Wall St. Rank hold BIOA as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining BioAmber Inc. position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 11,900 BioAmber Inc. shares in Q2 2014, an estimated $136K.
  • BlueCrest Capital Management (UK) first reported a position in BioAmber Inc. in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s BioAmber Inc. position peaked at $136K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.